AU Patent

AU2010299816B2 — Benzoxazepin PI3K inhibitor compounds and methods of use

Assigned to F Hoffmann La Roche AG · Expires 2015-11-12 · 11y expired

What this patent protects

The invention relates to benzoxazepin compounds of Formula (I) including stereoisomers, geometric isomers, tautomers, or pharmaceutically acceptable salts thereof, wherein: Z

USPTO Abstract

The invention relates to benzoxazepin compounds of Formula (I) including stereoisomers, geometric isomers, tautomers, or pharmaceutically acceptable salts thereof, wherein: Z

Drugs covered by this patent

Patent Metadata

Patent number
AU2010299816B2
Jurisdiction
AU
Classification
—
Expires
2015-11-12
Drug substance claim
No
Drug product claim
No
Assignee
F Hoffmann La Roche AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.